Drug research

9-ING-41

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as 9-ING-41 Compound

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Actuate 1901: 9-ING-41 in MyelofibrosisNCT04218071	ACTU	Phase 2	Completed	2022-10-13Actual
9-ING-41 in Patients With Advanced CancersNCT03678883	ACTU	Phase 2	Active not recruiting	2026-06Estimated

ACTUCompletedPrimary completion: 2022-10-13 · Actual

Trial details

ACTUActive not recruitingPrimary completion: 2026-06 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.